nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.146	0.298	CbGbCtD
Amoxapine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.047	0.0959	CbGbCtD
Amoxapine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0442	0.0902	CbGbCtD
Amoxapine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0442	0.0902	CbGbCtD
Amoxapine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0399	0.0816	CbGbCtD
Amoxapine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0399	0.0816	CbGbCtD
Amoxapine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0345	0.0704	CbGbCtD
Amoxapine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0335	0.0684	CbGbCtD
Amoxapine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0303	0.0618	CbGbCtD
Amoxapine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0303	0.0618	CbGbCtD
Amoxapine—ORM1—saliva—acquired immunodeficiency syndrome	0.0058	0.05	CbGeAlD
Amoxapine—DRD1—nerve—acquired immunodeficiency syndrome	0.00386	0.0333	CbGeAlD
Amoxapine—HTR3A—nerve—acquired immunodeficiency syndrome	0.00373	0.0322	CbGeAlD
Amoxapine—HRH4—blood—acquired immunodeficiency syndrome	0.00313	0.027	CbGeAlD
Amoxapine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.0031	0.0268	CbGeAlD
Amoxapine—HRH4—bone marrow—acquired immunodeficiency syndrome	0.00303	0.0261	CbGeAlD
Amoxapine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.0025	0.0216	CbGeAlD
Amoxapine—HTR7—nerve—acquired immunodeficiency syndrome	0.00241	0.0208	CbGeAlD
Amoxapine—DRD2—nerve—acquired immunodeficiency syndrome	0.00228	0.0197	CbGeAlD
Amoxapine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00215	0.0185	CbGeAlD
Amoxapine—HTR7—endothelium—acquired immunodeficiency syndrome	0.00205	0.0177	CbGeAlD
Amoxapine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00191	0.0165	CbGeAlD
Amoxapine—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00182	0.0157	CbGeAlD
Amoxapine—HTR2A—nerve—acquired immunodeficiency syndrome	0.0015	0.013	CbGeAlD
Amoxapine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00134	0.0115	CbGeAlD
Amoxapine—DRD4—brain—acquired immunodeficiency syndrome	0.00132	0.0114	CbGeAlD
Amoxapine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00128	0.011	CbGeAlD
Amoxapine—DRD3—nervous system—acquired immunodeficiency syndrome	0.00121	0.0105	CbGeAlD
Amoxapine—DRD3—central nervous system—acquired immunodeficiency syndrome	0.00117	0.0101	CbGeAlD
Amoxapine—HTR6—nervous system—acquired immunodeficiency syndrome	0.00117	0.0101	CbGeAlD
Amoxapine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00114	0.00981	CbGeAlD
Amoxapine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.00112	0.00969	CbGeAlD
Amoxapine—HTR3A—digestive system—acquired immunodeficiency syndrome	0.00108	0.00935	CbGeAlD
Amoxapine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00104	0.00894	CbGeAlD
Amoxapine—HTR3A—blood—acquired immunodeficiency syndrome	0.00103	0.00891	CbGeAlD
Amoxapine—HTR2B—skin of body—acquired immunodeficiency syndrome	0.00102	0.00883	CbGeAlD
Amoxapine—DRD2—retina—acquired immunodeficiency syndrome	0.000944	0.00815	CbGeAlD
Amoxapine—DRD3—brain—acquired immunodeficiency syndrome	0.000927	0.00799	CbGeAlD
Amoxapine—ORM1—blood—acquired immunodeficiency syndrome	0.000924	0.00797	CbGeAlD
Amoxapine—HTR3A—lung—acquired immunodeficiency syndrome	0.000905	0.00781	CbGeAlD
Amoxapine—ORM1—bone marrow—acquired immunodeficiency syndrome	0.000894	0.00771	CbGeAlD
Amoxapine—HTR6—brain—acquired immunodeficiency syndrome	0.000892	0.00769	CbGeAlD
Amoxapine—ORM1—spinal cord—acquired immunodeficiency syndrome	0.00089	0.00768	CbGeAlD
Amoxapine—DRD1—nervous system—acquired immunodeficiency syndrome	0.000868	0.00749	CbGeAlD
Amoxapine—HTR3A—nervous system—acquired immunodeficiency syndrome	0.000838	0.00723	CbGeAlD
Amoxapine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000836	0.00721	CbGeAlD
Amoxapine—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.000835	0.0072	CbGeAlD
Amoxapine—GABRA1—spinal cord—acquired immunodeficiency syndrome	0.000835	0.0072	CbGeAlD
Amoxapine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000828	0.00714	CbGeAlD
Amoxapine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000827	0.00713	CbGeAlD
Amoxapine—HTR2B—digestive system—acquired immunodeficiency syndrome	0.000819	0.00707	CbGeAlD
Amoxapine—ORM1—lung—acquired immunodeficiency syndrome	0.00081	0.00699	CbGeAlD
Amoxapine—HTR3A—central nervous system—acquired immunodeficiency syndrome	0.000807	0.00696	CbGeAlD
Amoxapine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.0008	0.0069	CbGeAlD
Amoxapine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000788	0.00679	CbGeAlD
Amoxapine—HTR2B—blood—acquired immunodeficiency syndrome	0.00078	0.00673	CbGeAlD
Amoxapine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000759	0.00655	CbGeAlD
Amoxapine—SLC6A3—lung—acquired immunodeficiency syndrome	0.000753	0.0065	CbGeAlD
Amoxapine—ORM1—nervous system—acquired immunodeficiency syndrome	0.00075	0.00647	CbGeAlD
Amoxapine—HTR2B—vagina—acquired immunodeficiency syndrome	0.000723	0.00624	CbGeAlD
Amoxapine—ORM1—central nervous system—acquired immunodeficiency syndrome	0.000722	0.00623	CbGeAlD
Amoxapine—HTR1B—nervous system—acquired immunodeficiency syndrome	0.000703	0.00607	CbGeAlD
Amoxapine—GABRA1—nervous system—acquired immunodeficiency syndrome	0.000703	0.00607	CbGeAlD
Amoxapine—HTR7—digestive system—acquired immunodeficiency syndrome	0.000701	0.00605	CbGeAlD
Amoxapine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000698	0.00602	CbGeAlD
Amoxapine—SLC6A4—lung—acquired immunodeficiency syndrome	0.00069	0.00596	CbGeAlD
Amoxapine—CHRM1—lung—acquired immunodeficiency syndrome	0.000688	0.00593	CbGeAlD
Amoxapine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000685	0.00591	CbGeAlD
Amoxapine—HTR2B—lung—acquired immunodeficiency syndrome	0.000684	0.0059	CbGeAlD
Amoxapine—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000677	0.00584	CbGeAlD
Amoxapine—GABRA1—central nervous system—acquired immunodeficiency syndrome	0.000677	0.00584	CbGeAlD
Amoxapine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000674	0.00582	CbGeAlD
Amoxapine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000674	0.00581	CbGeAlD
Amoxapine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000672	0.00579	CbGeAlD
Amoxapine—HTR7—blood—acquired immunodeficiency syndrome	0.000668	0.00576	CbGeAlD
Amoxapine—DRD1—brain—acquired immunodeficiency syndrome	0.000664	0.00572	CbGeAlD
Amoxapine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000649	0.0056	CbGeAlD
Amoxapine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000645	0.00556	CbGeAlD
Amoxapine—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000644	0.00555	CbGeAlD
Amoxapine—HTR3A—brain—acquired immunodeficiency syndrome	0.000641	0.00553	CbGeAlD
Amoxapine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000639	0.00551	CbGeAlD
Amoxapine—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000637	0.00549	CbGeAlD
Amoxapine—HTR2B—nervous system—acquired immunodeficiency syndrome	0.000633	0.00546	CbGeAlD
Amoxapine—HTR2A—retina—acquired immunodeficiency syndrome	0.000623	0.00537	CbGeAlD
Amoxapine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000616	0.00531	CbGeAlD
Amoxapine—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.000613	0.00529	CbGeAlD
Amoxapine—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.00061	0.00526	CbGeAlD
Amoxapine—SLC6A2—lung—acquired immunodeficiency syndrome	0.000608	0.00524	CbGeAlD
Amoxapine—HTR7—lung—acquired immunodeficiency syndrome	0.000586	0.00505	CbGeAlD
Amoxapine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000568	0.0049	CbGeAlD
Amoxapine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000563	0.00486	CbGeAlD
Amoxapine—ORM1—lymph node—acquired immunodeficiency syndrome	0.000554	0.00478	CbGeAlD
Amoxapine—DRD2—lung—acquired immunodeficiency syndrome	0.000554	0.00478	CbGeAlD
Amoxapine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000547	0.00471	CbGeAlD
Amoxapine—HTR7—nervous system—acquired immunodeficiency syndrome	0.000542	0.00468	CbGeAlD
Amoxapine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000542	0.00467	CbGeAlD
Amoxapine—HTR1B—brain—acquired immunodeficiency syndrome	0.000538	0.00464	CbGeAlD
Amoxapine—GABRA1—brain—acquired immunodeficiency syndrome	0.000538	0.00464	CbGeAlD
Amoxapine—SLC6A3—brain—acquired immunodeficiency syndrome	0.000533	0.0046	CbGeAlD
Amoxapine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000524	0.00452	CbGeAlD
Amoxapine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000523	0.00451	CbGeAlD
Amoxapine—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000522	0.00451	CbGeAlD
Amoxapine—HTR2C—brain—acquired immunodeficiency syndrome	0.000515	0.00445	CbGeAlD
Amoxapine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000513	0.00442	CbGeAlD
Amoxapine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000504	0.00435	CbGeAlD
Amoxapine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000494	0.00426	CbGeAlD
Amoxapine—ADRA2A—blood—acquired immunodeficiency syndrome	0.00049	0.00423	CbGeAlD
Amoxapine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000489	0.00422	CbGeAlD
Amoxapine—CHRM1—brain—acquired immunodeficiency syndrome	0.000487	0.0042	CbGeAlD
Amoxapine—HTR2B—brain—acquired immunodeficiency syndrome	0.000484	0.00418	CbGeAlD
Amoxapine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000472	0.00407	CbGeAlD
Amoxapine—HTR2B—lymph node—acquired immunodeficiency syndrome	0.000468	0.00404	CbGeAlD
Amoxapine—HRH1—vagina—acquired immunodeficiency syndrome	0.000462	0.00399	CbGeAlD
Amoxapine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000454	0.00392	CbGeAlD
Amoxapine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000437	0.00377	CbGeAlD
Amoxapine—HRH1—lung—acquired immunodeficiency syndrome	0.000437	0.00377	CbGeAlD
Amoxapine—HTR1A—brain—acquired immunodeficiency syndrome	0.000434	0.00374	CbGeAlD
Amoxapine—SLC6A2—brain—acquired immunodeficiency syndrome	0.00043	0.00371	CbGeAlD
Amoxapine—ADRA2A—lung—acquired immunodeficiency syndrome	0.00043	0.00371	CbGeAlD
Amoxapine—HTR2A—blood—acquired immunodeficiency syndrome	0.000417	0.00359	CbGeAlD
Amoxapine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000416	0.00359	CbGeAlD
Amoxapine—HTR7—brain—acquired immunodeficiency syndrome	0.000415	0.00358	CbGeAlD
Amoxapine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000413	0.00137	CcSEcCtD
Amoxapine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000413	0.00137	CcSEcCtD
Amoxapine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000411	0.00136	CcSEcCtD
Amoxapine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00041	0.00136	CcSEcCtD
Amoxapine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00041	0.00136	CcSEcCtD
Amoxapine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000409	0.00136	CcSEcCtD
Amoxapine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000409	0.00135	CcSEcCtD
Amoxapine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000408	0.00135	CcSEcCtD
Amoxapine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000406	0.00134	CcSEcCtD
Amoxapine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000405	0.00349	CbGeAlD
Amoxapine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000404	0.00134	CcSEcCtD
Amoxapine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000401	0.00346	CbGeAlD
Amoxapine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000401	0.00133	CcSEcCtD
Amoxapine—ADRA1A—brain—acquired immunodeficiency syndrome	0.0004	0.00345	CbGeAlD
Amoxapine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000399	0.00132	CcSEcCtD
Amoxapine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000398	0.00344	CbGeAlD
Amoxapine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000398	0.00132	CcSEcCtD
Amoxapine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000398	0.00343	CbGeAlD
Amoxapine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000398	0.00132	CcSEcCtD
Amoxapine—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000397	0.00132	CcSEcCtD
Amoxapine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000397	0.00131	CcSEcCtD
Amoxapine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000396	0.00131	CcSEcCtD
Amoxapine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.00131	CcSEcCtD
Amoxapine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000395	0.00131	CcSEcCtD
Amoxapine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000395	0.00131	CcSEcCtD
Amoxapine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000395	0.00131	CcSEcCtD
Amoxapine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000394	0.00131	CcSEcCtD
Amoxapine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000394	0.00131	CcSEcCtD
Amoxapine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000394	0.0013	CcSEcCtD
Amoxapine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000393	0.0013	CcSEcCtD
Amoxapine—DRD2—brain—acquired immunodeficiency syndrome	0.000392	0.00338	CbGeAlD
Amoxapine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000392	0.0013	CcSEcCtD
Amoxapine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000391	0.00129	CcSEcCtD
Amoxapine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.00039	0.00336	CbGeAlD
Amoxapine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000389	0.00129	CcSEcCtD
Amoxapine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000388	0.00129	CcSEcCtD
Amoxapine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000388	0.00129	CcSEcCtD
Amoxapine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000388	0.00129	CcSEcCtD
Amoxapine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000388	0.00128	CcSEcCtD
Amoxapine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000388	0.00128	CcSEcCtD
Amoxapine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000386	0.00333	CbGeAlD
Amoxapine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000386	0.00128	CcSEcCtD
Amoxapine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000386	0.00128	CcSEcCtD
Amoxapine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000385	0.00128	CcSEcCtD
Amoxapine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000385	0.00127	CcSEcCtD
Amoxapine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000385	0.00127	CcSEcCtD
Amoxapine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000383	0.0033	CbGeAlD
Amoxapine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000383	0.00127	CcSEcCtD
Amoxapine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000382	0.00126	CcSEcCtD
Amoxapine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000381	0.00126	CcSEcCtD
Amoxapine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000381	0.00126	CcSEcCtD
Amoxapine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000381	0.00126	CcSEcCtD
Amoxapine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000381	0.00126	CcSEcCtD
Amoxapine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00038	0.00126	CcSEcCtD
Amoxapine—CYP2D6—blood—acquired immunodeficiency syndrome	0.00038	0.00327	CbGeAlD
Amoxapine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00038	0.00126	CcSEcCtD
Amoxapine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000379	0.00126	CcSEcCtD
Amoxapine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000379	0.00126	CcSEcCtD
Amoxapine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000378	0.00125	CcSEcCtD
Amoxapine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000378	0.00125	CcSEcCtD
Amoxapine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000378	0.00125	CcSEcCtD
Amoxapine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000377	0.00125	CcSEcCtD
Amoxapine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.00125	CcSEcCtD
Amoxapine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000376	0.00125	CcSEcCtD
Amoxapine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000376	0.00124	CcSEcCtD
Amoxapine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000375	0.00124	CcSEcCtD
Amoxapine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000375	0.00124	CcSEcCtD
Amoxapine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000373	0.00123	CcSEcCtD
Amoxapine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000372	0.00123	CcSEcCtD
Amoxapine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00037	0.00122	CcSEcCtD
Amoxapine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00037	0.00122	CcSEcCtD
Amoxapine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000369	0.00122	CcSEcCtD
Amoxapine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000367	0.00121	CcSEcCtD
Amoxapine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000366	0.00121	CcSEcCtD
Amoxapine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000366	0.00121	CcSEcCtD
Amoxapine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000366	0.00121	CcSEcCtD
Amoxapine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000366	0.00121	CcSEcCtD
Amoxapine—HTR2A—lung—acquired immunodeficiency syndrome	0.000365	0.00315	CbGeAlD
Amoxapine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000365	0.00121	CcSEcCtD
Amoxapine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000364	0.00121	CcSEcCtD
Amoxapine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000364	0.00121	CcSEcCtD
Amoxapine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000364	0.00121	CcSEcCtD
Amoxapine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000364	0.0012	CcSEcCtD
Amoxapine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000363	0.0012	CcSEcCtD
Amoxapine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000363	0.0012	CcSEcCtD
Amoxapine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000362	0.0012	CcSEcCtD
Amoxapine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000362	0.0012	CcSEcCtD
Amoxapine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000361	0.0012	CcSEcCtD
Amoxapine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.0012	CcSEcCtD
Amoxapine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00036	0.00119	CcSEcCtD
Amoxapine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000358	0.00119	CcSEcCtD
Amoxapine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000358	0.00118	CcSEcCtD
Amoxapine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000357	0.00118	CcSEcCtD
Amoxapine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000354	0.00117	CcSEcCtD
Amoxapine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000353	0.00117	CcSEcCtD
Amoxapine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000353	0.00117	CcSEcCtD
Amoxapine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000352	0.00117	CcSEcCtD
Amoxapine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000352	0.00117	CcSEcCtD
Amoxapine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000352	0.00117	CcSEcCtD
Amoxapine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000351	0.00116	CcSEcCtD
Amoxapine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000351	0.00116	CcSEcCtD
Amoxapine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000351	0.00116	CcSEcCtD
Amoxapine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000351	0.00116	CcSEcCtD
Amoxapine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00035	0.00116	CcSEcCtD
Amoxapine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000349	0.00116	CcSEcCtD
Amoxapine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000349	0.00116	CcSEcCtD
Amoxapine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000349	0.00116	CcSEcCtD
Amoxapine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00115	CcSEcCtD
Amoxapine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.00115	CcSEcCtD
Amoxapine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000346	0.00115	CcSEcCtD
Amoxapine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000346	0.00115	CcSEcCtD
Amoxapine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000346	0.00115	CcSEcCtD
Amoxapine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000346	0.00114	CcSEcCtD
Amoxapine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000345	0.00114	CcSEcCtD
Amoxapine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000345	0.00114	CcSEcCtD
Amoxapine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000344	0.00114	CcSEcCtD
Amoxapine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000342	0.00113	CcSEcCtD
Amoxapine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000341	0.00113	CcSEcCtD
Amoxapine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000341	0.00113	CcSEcCtD
Amoxapine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000339	0.00112	CcSEcCtD
Amoxapine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000339	0.00112	CcSEcCtD
Amoxapine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000339	0.00112	CcSEcCtD
Amoxapine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000338	0.00112	CcSEcCtD
Amoxapine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000338	0.00292	CbGeAlD
Amoxapine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000338	0.00112	CcSEcCtD
Amoxapine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000337	0.00112	CcSEcCtD
Amoxapine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000337	0.00112	CcSEcCtD
Amoxapine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000336	0.00111	CcSEcCtD
Amoxapine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000335	0.00111	CcSEcCtD
Amoxapine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000335	0.00111	CcSEcCtD
Amoxapine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000335	0.00111	CcSEcCtD
Amoxapine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000334	0.00111	CcSEcCtD
Amoxapine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000334	0.00111	CcSEcCtD
Amoxapine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000334	0.00111	CcSEcCtD
Amoxapine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000334	0.00111	CcSEcCtD
Amoxapine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000333	0.0011	CcSEcCtD
Amoxapine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000332	0.0011	CcSEcCtD
Amoxapine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000332	0.0011	CcSEcCtD
Amoxapine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.0011	CcSEcCtD
Amoxapine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000331	0.0011	CcSEcCtD
Amoxapine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000331	0.0011	CcSEcCtD
Amoxapine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000331	0.0011	CcSEcCtD
Amoxapine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000329	0.00109	CcSEcCtD
Amoxapine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000329	0.00109	CcSEcCtD
Amoxapine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000329	0.00109	CcSEcCtD
Amoxapine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000329	0.00109	CcSEcCtD
Amoxapine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000327	0.00108	CcSEcCtD
Amoxapine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000326	0.00108	CcSEcCtD
Amoxapine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000326	0.00108	CcSEcCtD
Amoxapine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000326	0.00281	CbGeAlD
Amoxapine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000324	0.00107	CcSEcCtD
Amoxapine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000324	0.00107	CcSEcCtD
Amoxapine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000322	0.00107	CcSEcCtD
Amoxapine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.00107	CcSEcCtD
Amoxapine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00107	CcSEcCtD
Amoxapine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000322	0.00107	CcSEcCtD
Amoxapine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00032	0.00106	CcSEcCtD
Amoxapine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00032	0.00106	CcSEcCtD
Amoxapine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000319	0.00106	CcSEcCtD
Amoxapine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000319	0.00106	CcSEcCtD
Amoxapine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.00105	CcSEcCtD
Amoxapine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000316	0.00105	CcSEcCtD
Amoxapine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.00104	CcSEcCtD
Amoxapine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000315	0.00104	CcSEcCtD
Amoxapine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000315	0.00104	CcSEcCtD
Amoxapine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000314	0.00104	CcSEcCtD
Amoxapine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000312	0.00103	CcSEcCtD
Amoxapine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000312	0.00103	CcSEcCtD
Amoxapine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00031	0.00103	CcSEcCtD
Amoxapine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.00103	CcSEcCtD
Amoxapine—HRH1—brain—acquired immunodeficiency syndrome	0.00031	0.00267	CbGeAlD
Amoxapine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000309	0.00102	CcSEcCtD
Amoxapine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000308	0.00266	CbGeAlD
Amoxapine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000308	0.00102	CcSEcCtD
Amoxapine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000308	0.00102	CcSEcCtD
Amoxapine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000308	0.00102	CcSEcCtD
Amoxapine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000307	0.00102	CcSEcCtD
Amoxapine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000307	0.00102	CcSEcCtD
Amoxapine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.00101	CcSEcCtD
Amoxapine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.00101	CcSEcCtD
Amoxapine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000305	0.00101	CcSEcCtD
Amoxapine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000304	0.00262	CbGeAlD
Amoxapine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00101	CcSEcCtD
Amoxapine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000303	0.001	CcSEcCtD
Amoxapine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.0003	0.000993	CcSEcCtD
Amoxapine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000299	0.00258	CbGeAlD
Amoxapine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000298	0.000986	CcSEcCtD
Amoxapine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000297	0.000985	CcSEcCtD
Amoxapine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000297	0.00256	CbGeAlD
Amoxapine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.000979	CcSEcCtD
Amoxapine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000295	0.000978	CcSEcCtD
Amoxapine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.000977	CcSEcCtD
Amoxapine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000294	0.00253	CbGeAlD
Amoxapine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000293	0.000972	CcSEcCtD
Amoxapine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000293	0.000971	CcSEcCtD
Amoxapine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.000971	CcSEcCtD
Amoxapine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000293	0.000969	CcSEcCtD
Amoxapine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000291	0.000963	CcSEcCtD
Amoxapine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000291	0.000963	CcSEcCtD
Amoxapine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00029	0.000962	CcSEcCtD
Amoxapine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.000959	CcSEcCtD
Amoxapine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000289	0.000956	CcSEcCtD
Amoxapine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000287	0.000949	CcSEcCtD
Amoxapine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.000947	CcSEcCtD
Amoxapine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000285	0.000943	CcSEcCtD
Amoxapine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000284	0.000941	CcSEcCtD
Amoxapine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000284	0.00094	CcSEcCtD
Amoxapine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000284	0.000939	CcSEcCtD
Amoxapine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.000938	CcSEcCtD
Amoxapine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.000938	CcSEcCtD
Amoxapine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.000934	CcSEcCtD
Amoxapine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.000932	CcSEcCtD
Amoxapine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.000921	CcSEcCtD
Amoxapine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000277	0.000918	CcSEcCtD
Amoxapine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.000908	CcSEcCtD
Amoxapine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000274	0.000908	CcSEcCtD
Amoxapine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000274	0.000907	CcSEcCtD
Amoxapine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.000903	CcSEcCtD
Amoxapine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.000903	CcSEcCtD
Amoxapine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000273	0.000903	CcSEcCtD
Amoxapine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.000898	CcSEcCtD
Amoxapine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00027	0.000895	CcSEcCtD
Amoxapine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00027	0.000894	CcSEcCtD
Amoxapine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.000891	CcSEcCtD
Amoxapine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000269	0.00089	CcSEcCtD
Amoxapine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000268	0.000887	CcSEcCtD
Amoxapine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.000878	CcSEcCtD
Amoxapine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000261	0.000866	CcSEcCtD
Amoxapine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.000862	CcSEcCtD
Amoxapine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.000862	CcSEcCtD
Amoxapine—HTR2A—brain—acquired immunodeficiency syndrome	0.000259	0.00223	CbGeAlD
Amoxapine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.000853	CcSEcCtD
Amoxapine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.000852	CcSEcCtD
Amoxapine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000256	0.000849	CcSEcCtD
Amoxapine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.000846	CcSEcCtD
Amoxapine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.000845	CcSEcCtD
Amoxapine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000255	0.000843	CcSEcCtD
Amoxapine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.00084	CcSEcCtD
Amoxapine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.00084	CcSEcCtD
Amoxapine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.00082	CcSEcCtD
Amoxapine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.000816	CcSEcCtD
Amoxapine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.000812	CcSEcCtD
Amoxapine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.000809	CcSEcCtD
Amoxapine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.000809	CcSEcCtD
Amoxapine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.000808	CcSEcCtD
Amoxapine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.000804	CcSEcCtD
Amoxapine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000241	0.000797	CcSEcCtD
Amoxapine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000237	0.000785	CcSEcCtD
Amoxapine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.000782	CcSEcCtD
Amoxapine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.000782	CcSEcCtD
Amoxapine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000236	0.00203	CbGeAlD
Amoxapine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.000771	CcSEcCtD
Amoxapine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.000762	CcSEcCtD
Amoxapine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.000755	CcSEcCtD
Amoxapine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000755	CcSEcCtD
Amoxapine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000748	CcSEcCtD
Amoxapine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000748	CcSEcCtD
Amoxapine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.000746	CcSEcCtD
Amoxapine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.000744	CcSEcCtD
Amoxapine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000726	CcSEcCtD
Amoxapine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000721	CcSEcCtD
Amoxapine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.00072	CcSEcCtD
Amoxapine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.00072	CcSEcCtD
Amoxapine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000716	CcSEcCtD
Amoxapine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.000705	CcSEcCtD
Amoxapine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000693	CcSEcCtD
Amoxapine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000687	CcSEcCtD
Amoxapine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000687	CcSEcCtD
Amoxapine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000683	CcSEcCtD
Amoxapine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000679	CcSEcCtD
Amoxapine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000647	CcSEcCtD
Amoxapine—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.68e-05	0.000398	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.66e-05	0.000397	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.63e-05	0.000393	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.63e-05	0.000392	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.62e-05	0.000392	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.62e-05	0.000392	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.61e-05	0.000391	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.58e-05	0.000388	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.58e-05	0.000387	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.56e-05	0.000386	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.53e-05	0.000382	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.53e-05	0.000382	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.51e-05	0.00038	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.47e-05	0.000376	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.46e-05	0.000374	CbGpPWpGaD
Amoxapine—SLC6A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.44e-05	0.000373	CbGpPWpGaD
Amoxapine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.42e-05	0.00037	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.42e-05	0.00037	CbGpPWpGaD
Amoxapine—GABRA1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.41e-05	0.000369	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.41e-05	0.000369	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.41e-05	0.000369	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.41e-05	0.000369	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.41e-05	0.000369	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.41e-05	0.000369	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.41e-05	0.000369	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.36e-05	0.000364	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.36e-05	0.000364	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.36e-05	0.000364	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.32e-05	0.000359	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.32e-05	0.000359	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.31e-05	0.000359	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.26e-05	0.000353	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.26e-05	0.000353	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.25e-05	0.000352	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.24e-05	0.00035	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.23e-05	0.000349	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.21e-05	0.000348	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.21e-05	0.000347	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.19e-05	0.000345	CbGpPWpGaD
Amoxapine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.19e-05	0.000345	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.15e-05	0.00034	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.13e-05	0.000338	CbGpPWpGaD
Amoxapine—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.12e-05	0.000338	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.12e-05	0.000337	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.12e-05	0.000337	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.1e-05	0.000335	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.1e-05	0.000335	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.09e-05	0.000334	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.08e-05	0.000334	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.08e-05	0.000333	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.05e-05	0.00033	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.04e-05	0.000329	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.03e-05	0.000328	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.03e-05	0.000328	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.99e-05	0.000323	CbGpPWpGaD
Amoxapine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.97e-05	0.000322	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.97e-05	0.000322	CbGpPWpGaD
Amoxapine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.97e-05	0.000321	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.96e-05	0.00032	CbGpPWpGaD
Amoxapine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.96e-05	0.00032	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.94e-05	0.000318	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.94e-05	0.000318	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.93e-05	0.000317	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.92e-05	0.000316	CbGpPWpGaD
Amoxapine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.91e-05	0.000315	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.9e-05	0.000314	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.9e-05	0.000314	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	2.86e-05	0.00031	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.86e-05	0.000309	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.83e-05	0.000307	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.82e-05	0.000305	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.81e-05	0.000305	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.81e-05	0.000304	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.8e-05	0.000304	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.8e-05	0.000303	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.79e-05	0.000302	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.78e-05	0.000301	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.77e-05	0.0003	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.77e-05	0.0003	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.77e-05	0.0003	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.76e-05	0.000299	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.75e-05	0.000298	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.75e-05	0.000298	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.73e-05	0.000296	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.71e-05	0.000293	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.69e-05	0.000291	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.67e-05	0.000289	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.61e-05	0.000282	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.6e-05	0.000281	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.59e-05	0.000281	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.57e-05	0.000279	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.57e-05	0.000278	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.56e-05	0.000277	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.56e-05	0.000277	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.56e-05	0.000277	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.55e-05	0.000277	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.55e-05	0.000276	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.54e-05	0.000275	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.53e-05	0.000274	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.53e-05	0.000273	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.53e-05	0.000273	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.53e-05	0.000273	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.52e-05	0.000273	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.52e-05	0.000273	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.52e-05	0.000273	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.52e-05	0.000273	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.52e-05	0.000272	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.51e-05	0.000272	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.51e-05	0.000272	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.51e-05	0.000272	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.49e-05	0.000269	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.48e-05	0.000269	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.48e-05	0.000268	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.45e-05	0.000265	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.45e-05	0.000265	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.41e-05	0.000261	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.37e-05	0.000257	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.36e-05	0.000255	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.34e-05	0.000253	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.34e-05	0.000253	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.34e-05	0.000253	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.33e-05	0.000253	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.32e-05	0.000251	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	2.32e-05	0.000251	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.32e-05	0.000251	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.31e-05	0.00025	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.3e-05	0.000249	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.3e-05	0.000249	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.29e-05	0.000248	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.29e-05	0.000247	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.27e-05	0.000246	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.27e-05	0.000246	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.27e-05	0.000246	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.26e-05	0.000245	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.24e-05	0.000242	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.24e-05	0.000242	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.22e-05	0.000241	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.22e-05	0.00024	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.22e-05	0.00024	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.21e-05	0.000239	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.2e-05	0.000238	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.19e-05	0.000237	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.18e-05	0.000236	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.18e-05	0.000236	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.18e-05	0.000236	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.18e-05	0.000236	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.17e-05	0.000235	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.17e-05	0.000235	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.17e-05	0.000235	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.17e-05	0.000235	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.14e-05	0.000232	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.14e-05	0.000231	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.14e-05	0.000231	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.14e-05	0.000231	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.11e-05	0.000229	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.09e-05	0.000226	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.01e-05	0.000218	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.99e-05	0.000215	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.99e-05	0.000215	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.99e-05	0.000215	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.97e-05	0.000213	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.94e-05	0.00021	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.92e-05	0.000208	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.91e-05	0.000207	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.89e-05	0.000205	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.88e-05	0.000204	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.87e-05	0.000202	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.86e-05	0.000201	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.73e-05	0.000187	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.72e-05	0.000186	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.69e-05	0.000183	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.69e-05	0.000183	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.68e-05	0.000182	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.66e-05	0.00018	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.66e-05	0.00018	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.66e-05	0.000179	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.65e-05	0.000179	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.64e-05	0.000177	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.64e-05	0.000177	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.63e-05	0.000177	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.63e-05	0.000176	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.63e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.61e-05	0.000174	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.61e-05	0.000174	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.6e-05	0.000173	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.6e-05	0.000173	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.58e-05	0.000171	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.52e-05	0.000165	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.51e-05	0.000163	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.5e-05	0.000162	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000162	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.49e-05	0.000161	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000161	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.49e-05	0.000161	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.47e-05	0.000159	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000159	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000158	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000158	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000158	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000155	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.36e-05	0.000147	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.35e-05	0.000146	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.35e-05	0.000146	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.34e-05	0.000146	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.34e-05	0.000145	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.34e-05	0.000145	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000144	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.31e-05	0.000142	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.31e-05	0.000141	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.29e-05	0.00014	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.29e-05	0.000139	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.23e-05	0.000134	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.23e-05	0.000133	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.16e-05	0.000126	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	1.16e-05	0.000126	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.16e-05	0.000125	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.15e-05	0.000124	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.14e-05	0.000124	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1e-05	0.000108	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.96e-06	0.000108	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.95e-06	0.000108	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.9e-06	0.000107	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.78e-06	9.51e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.74e-06	9.46e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.64e-06	9.35e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.63e-06	9.33e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.6e-06	9.31e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.6e-06	9.3e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.58e-06	9.29e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.55e-06	9.26e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.46e-06	9.16e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.42e-06	9.11e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.94e-06	8.6e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.94e-06	8.59e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.86e-06	8.51e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.82e-06	8.47e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.72e-06	8.35e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.6e-06	8.22e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	7.56e-06	8.18e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.25e-06	7.85e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.84e-06	7.4e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.75e-06	7.3e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.88e-06	6.36e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.85e-06	6.33e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.16e-06	5.59e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.08e-06	5.5e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.07e-06	5.49e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.05e-06	5.47e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.97e-06	5.38e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.62e-06	5e-05	CbGpPWpGaD
